118 related articles for article (PubMed ID: 16831169)
1. Genetic variation in platelet integrin alphabeta (GPIIb/IIIa) and the metastatic potential of renal cell carcinoma.
Kallio JP; Mikkelsson J; Tammela TL; Karhunen PJ; Kellokumpu-Lehtinen P
BJU Int; 2006 Jul; 98(1):201-4. PubMed ID: 16831169
[TBL] [Abstract][Full Text] [Related]
2. The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets.
O'Halloran AM; Curtin R; O'Connor F; Dooley M; Fitzgerald A; O'Brien JK; Fitzgerald DJ; Shields DC
Br J Haematol; 2006 Feb; 132(4):494-502. PubMed ID: 16412022
[TBL] [Abstract][Full Text] [Related]
3. Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa Pl(A1/A2) polymorphisms and ischemic stroke in young Taiwanese.
Chen CH; Lo YK; Ke D; Liu CK; Liou CW; Wu HL; Lai ML;
J Neurol Sci; 2004 Dec; 227(1):1-5. PubMed ID: 15546585
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
5. Association of the GPIa C807T and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarction in men.
Benze G; Heinrich J; Schulte H; Rust S; Nowak-Göttl U; Tataru MC; Köhler E; Assmann G; Junker R
Eur Heart J; 2002 Feb; 23(4):325-30. PubMed ID: 11812069
[TBL] [Abstract][Full Text] [Related]
6. Association of C807T, Pl(A), and -5 C/T Kozak genotypes with density of glycoprotein receptors on platelet surface.
Huang T; Sahud MA
Thromb Res; 2003; 112(3):147-50. PubMed ID: 14967411
[TBL] [Abstract][Full Text] [Related]
7. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction.
Grove EL; Ørntoft TF; Lassen JF; Jensen HK; Kristensen SD
J Intern Med; 2004 Jun; 255(6):637-44. PubMed ID: 15147527
[TBL] [Abstract][Full Text] [Related]
8. Clinical and functional consequences of platelet membrane glycoprotein polymorphisms.
Yee DL; Bray PF
Semin Thromb Hemost; 2004 Oct; 30(5):591-600. PubMed ID: 15497101
[TBL] [Abstract][Full Text] [Related]
9. Platelet receptor polymorphisms and thrombotic risk.
Santoso S; Kunicki T
Ital Heart J; 2001 Nov; 2(11):811-5. PubMed ID: 11770864
[TBL] [Abstract][Full Text] [Related]
10. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
[TBL] [Abstract][Full Text] [Related]
11. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ
Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke.
Carlsson LE; Greinacher A; Spitzer C; Walther R; Kessler C
Stroke; 1997 Jul; 28(7):1392-5. PubMed ID: 9227689
[TBL] [Abstract][Full Text] [Related]
13. PIA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIIa and its correlation to cerebrovascular diseases: an appraisal.
Wiwanitkit V
Clin Appl Thromb Hemost; 2009; 15(4):458-60. PubMed ID: 18160561
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma.
Kleinrath T; Gassner C; Lackner P; Thurnher M; Ramoner R
J Clin Oncol; 2007 Mar; 25(7):845-51. PubMed ID: 17327605
[TBL] [Abstract][Full Text] [Related]
15. Common variations in platelet glycoproteins: pharmacogenomic implications.
Quinn MJ; Topol EJ
Pharmacogenomics; 2001 Nov; 2(4):341-52. PubMed ID: 11722284
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of the platelet glycoprotein IIIa Pl(A1/A2) polymorphism in three South African ethnic groups and its effect on platelet function.
Naran NH; Chetty N; Crowther NJ
Thromb Res; 2008; 123(2):316-23. PubMed ID: 18657307
[TBL] [Abstract][Full Text] [Related]
17. Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival.
Oksala NK; Heikkinen M; Mikkelsson J; Pohjasvaara T; Kaste M; Erkinjuntti T; Karhunen PJ
Stroke; 2007 Jan; 38(1):50-5. PubMed ID: 17138951
[TBL] [Abstract][Full Text] [Related]
18. Dose-related efficacy of aspirin after coronary surgery in patients With Pl(A2) polymorphism (NCT00262275).
Lim E; Carballo S; Cornelissen J; Ali ZA; Grignani R; Bellm S; Large S
Ann Thorac Surg; 2007 Jan; 83(1):134-8. PubMed ID: 17184645
[TBL] [Abstract][Full Text] [Related]
19. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
20. Platelet glycoprotein IIIa PlA1/A2 polymorphism and its relationship with diabetic nephropathy in type 2 diabetic patients.
Scaglione L; Gambino R; Lillaz E; Bo S; Cassader M; Pagano G; Cavallo-Perin P
Clin Nephrol; 2000 Apr; 53(4):253-6. PubMed ID: 10809411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
